Literature DB >> 28516757

Gastric Perforation Caused by an Intragastric Balloon: Endoscopic Findings.

In Kyung Yoo1, Hoon Jai Chun1, Yoon Tae Jeen1.   

Abstract

Intragastric balloon (IGB) insertion has been most frequently used in the West as an effective endoscopic treatment for morbid obesity, in practice. Recently, there is a growing number of cases requiring IGB deployment for obesity treatment in Korea. One of the reported complications of IGB use is gastric perforation. A 47-year-old woman was admitted to the hospital with mild symptoms, 7 weeks after having an IGB placed. Esophagogastroduodenoscopy was performed and gastric ulcer perforation was observed in the ulcer base, where food particles were impacted. Laparoscopic primary repair was done successfully. This was a case of gastric perforation, secondary to poor compliance with a proton-pump inhibitor (PPI). PPI and Helicobacter pylori eradication are important for ulcer prevention following IGB deployment.

Entities:  

Keywords:  Intragastric balloon; Obesity; Perforation

Year:  2017        PMID: 28516757      PMCID: PMC5719922          DOI: 10.5946/ce.2017.015

Source DB:  PubMed          Journal:  Clin Endosc        ISSN: 2234-2400


INTRODUCTION

Intragastric balloons (IGBs) are gaining popularity as a substitute for bariatric surgery [1]. Gastric perforation is a rare complication of IGB insertion and requires operative management. However, most serious complications present with obvious signs. We present a case of gastric perforation, 7 weeks after balloon deployment, with almost no complaint of abdominal pain despite food impaction at the perforation site. We also describe the endoscopic findings in gastric perforation caused by an IGB.

CASE REPORT

A 47-year-old woman with a body mass index (BMI) of 30 kg/m2 and a weight of 77 kg was admitted to the hospital because of mild epigastric pain. She had undergone IGB (Endball) insertion for weight loss 7 weeks prior, but had not been administered a proton-pump inhibitor (PPI), which is necessary after balloon insertion for at least one month. She had no history of other medication intake, such as non-steroidal anti-inflammatory medications, and she had not undergone any previous abdominal surgeries. She had no other known disease. Before presenting to our hospital, she visited another clinic where she had undergone chest radiography, during which a small amount of free air was seen (Fig. 1A). Physical examination showed mild tenderness, and her laboratory test results were unremarkable. Abdominal computed tomography showed the balloon within the stomach, with intraperitoneal free air (Fig. 1B). The provisional diagnosis was gastric perforation. Upper gastrointestinal endoscopy (GIF-Q260J; Olympus, Tokyo, Japan) was performed using carbon dioxide (CO2) gas to decompress the balloon and to attempt endoscopic closure of the defect. A 0.8-cm gastric ulcer covered with food particles was noted on the anterior wall of the lower gastric body (Fig. 2A). After food particles were removed with a clip device (HX-110LR; Olympus, Tokyo, Japan), a definite perforation was observed at the ulcer base (Fig. 2B, Supplementary Video 1). However, endoscopic closure could not be performed because the ulcer margin showed fibrosis and inflammation. The balloon was punctured and 500 mL of clear fluid was drained. It was difficult to remove the balloon; therefore, we decided to leave it in the stomach. The patient was transferred to the emergency surgery team. Laparoscopic primary repair was performed, and an omental patch was applied to the perforation. Irrigation and washing of the abdominal and pelvic cavities was done and a hemovac was inserted. Endoscopy was performed 7 days after surgery. The perforation was repaired (Fig. 3). Biopsy for histologic detection of Helicobacter pylori was positive. The eradication of H. pylori was then performed. The decompressed IGB was retrieved endoscopically. She was discharged in a stable condition 12 days later and was prescribed PPI.
Fig. 1.

(A) A small amount of free air was seen on chest radiography (arrow). (B) Computed tomography demonstrating gastric perforation (white arrow) caused by an intragastric balloon (black arrow).

Fig. 2.

(A) A gastric ulcer was noted on the anterior wall of the lower gastric body. (B) Definite perforation was observed at the ulcer base after food particles were removed.

Fig. 3.

The follow-up endoscopy showed the repaired perforation.

DISCUSSION

Recently, IGB insertion has been used as an effective minimally invasive endoscopic treatment for morbid obesity. IGB insertion is popular in Western countries due to the simplicity of the procedure and its applicability to various degrees of obesity. Currently, there is a growing need for IGB deployment to treat obesity in Korea. Common adverse events after IGB placement are pain (33.7%) and nausea (29%). Serious adverse events, such as small bowel obstruction, perforation, and death, occur with an incidence of 0.3%, 0.1%, and 0.08%, respectively [2]. Bowel perforation after IGB insertion occurs in 0.1% of cases. The mechanism of perforation is not well understood. Constant pressure from continuous contact of the balloon with the gastric wall may result in a gastric ulcer and induce perforation [3]. Complications of balloon insertion constitute a diagnostic challenge because patients sometimes present with non-specific symptoms [4]. In order to decrease the risk of complications, balloons should not stay in place for more than 6 months [5] and patients should use PPIs [6]. Prior gastric surgery resulting in an anatomical abnormality of the gastrointestinal tract is a contraindication for intragastric implantation [7]. In addition, we recommend H. pylori testing and treatment for the prevention of a peptic ulcer. IGB placement is effective and feasible for the management of obesity. However, physicians should be aware of potential complications. As in our case, perforation can present with mild symptoms. This is a case of gastric perforation secondary to poor compliance with PPIs, and it was evaluated through endoscopy. To our knowledge, this is the first such report [3]. Although the risk of perforation is low, PPI and H. pylori eradication are important for ulcer prevention following IGB deployment.
  7 in total

1.  What could happen if you insert a BioEnterics intragastric balloon after sleeve gastrectomy?

Authors:  Hiba Hassan El Hage Chehade; Ziad Omar El Khatib; Houssam Khodor Abtar
Journal:  Surg Obes Relat Dis       Date:  2015-06-03       Impact factor: 4.734

Review 2.  Endoscopic bariatric therapies.

Authors:  Barham K Abu Dayyeh; Steven A Edmundowicz; Sreenivasa Jonnalagadda; Nitin Kumar; Michael Larsen; Shelby Sullivan; Christopher C Thompson; Subhas Banerjee
Journal:  Gastrointest Endosc       Date:  2015-03-28       Impact factor: 9.427

Review 3.  Current endoscopic techniques in the treatment of obesity.

Authors:  Eduardo Espinet-Coll; Javier Nebreda-Durán; José Antonio Gómez-Valero; Miguel Muñoz-Navas; Jordi Pujol-Gebelli; Carmen Vila-Lolo; Antonio Martínez-Gómez; Antonio Juan-Creix-Comamala
Journal:  Rev Esp Enferm Dig       Date:  2012-02       Impact factor: 2.086

4.  Obesity treatment using a Bioenterics intragastric balloon (BIB)--preliminary Croatian results.

Authors:  Marko Nikolic; Gorana Mirosevic; Neven Ljubicic; Marko Boban; Vladimir Supanc; Borka Pezo Nikolic; Vanja Zjacic-Rotkvic; Miroslav Bekavac-Beslin; Petar Gacina
Journal:  Obes Surg       Date:  2011-08       Impact factor: 4.129

5.  BioEnterics Intragastric Balloon: The Italian Experience with 2,515 Patients.

Authors:  A Genco; T Bruni; S B Doldi; P Forestieri; M Marino; L Busetto; C Giardiello; L Angrisani; L Pecchioli; P Stornelli; F Puglisi; M Alkilani; A Nigri; N Di Lorenzo; F Furbetta; A Cascardo; M Cipriano; M Lorenzo; N Basso
Journal:  Obes Surg       Date:  2005-09       Impact factor: 4.129

6.  Intragastric balloon in the treatment of patients with morbid obesity.

Authors:  J D Evans; M H Scott
Journal:  Br J Surg       Date:  2001-09       Impact factor: 6.939

Review 7.  Gastric Perforation following Intragastric Balloon Insertion: Combined Endoscopic and Laparoscopic Approach for Management: Case Series and Review of Literature.

Authors:  Bassem M Abou Hussein; Ali A Khammas; Ali M Al Ani; Abeer H Swaleh; Sameer A Al Awadhi; Yousif H El Tayyeb; Alya S Al-Mazrouei; Faisal M Badri
Journal:  Obes Surg       Date:  2016-05       Impact factor: 4.129

  7 in total
  3 in total

1.  Stomach Volume Assessment Using Three-dimensional Computed Tomography Gastrography for Bariatric Treatment.

Authors:  Seung Han Kim; Bora Keum; Hyuk Soon Choi; Eun Sun Kim; Yeon Seok Seo; Yoon Tae Jeen; Hong Sik Lee; Hoon Jai Chun; Soon Ho Um; Chang Duck Kim
Journal:  Obes Surg       Date:  2020-02       Impact factor: 4.129

2.  Currently Available Non-Balloon Devices.

Authors:  Hang Lak Lee
Journal:  Clin Endosc       Date:  2018-09-27

3.  Exclusively endoscopic approach to treating gastric perforation caused by an intragastric balloon: case series and literature review.

Authors:  Sérgio Alexandre Barrichello Junior; Igor Braga Ribeiro; Ricardo José Fittipaldi-Fernandez; Ana Carolina Hoff; Diogo Turiani Hourneaux de Moura; Mauricio Kazuyoshi Minata; Thiago Ferreira de Souza; Manoel Dos Passos Galvão Neto; Eduardo Guimarães Hourneaux de Moura
Journal:  Endosc Int Open       Date:  2018-11-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.